These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23135940)

  • 1. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
    LaSala PR; Ekhmimi T; Hill AK; Farooqi I; Perrotta PL
    J Clin Microbiol; 2013 Jan; 51(1):311-3. PubMed ID: 23135940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm.
    Wren MW; Kinson R; Sivapalan M; Shemko M; Shetty NR
    Br J Biomed Sci; 2009; 66(4):175-9. PubMed ID: 20095124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.
    Landry ML; Ferguson D; Topal J
    J Clin Microbiol; 2014 Jan; 52(1):275-80. PubMed ID: 24226924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.
    Riley TV; Collins DA; Karunakaran R; Kahar MA; Adnan A; Hassan SA; Zainul NH; Rustam FRM; Wahab ZA; Ramli R; Lee YY; Hassan H
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection.
    Kim H; Kim WH; Kim M; Jeong SH; Lee K
    Ann Lab Med; 2014 May; 34(3):235-9. PubMed ID: 24790912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
    Leslie JL; Cohen SH; Solnick JV; Polage CR
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.
    Boone JH; Archbald-Pannone LR; Wickham KN; Carman RJ; Guerrant RL; Franck CT; Lyerly DM
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1045-51. PubMed ID: 24449345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory.
    Wren MW; Sivapalan M; Kinson R; Shetty NR
    Br J Biomed Sci; 2009; 66(1):1-5. PubMed ID: 19348118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
    Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of a polymerase chain reaction method in the detection of Clostridioides difficile.
    Jaqueti Aroca J; Molina Esteban LM; García-Arata I; García-Martínez J; Cano De Torres I; Prieto Menchero S
    Rev Esp Quimioter; 2021 Apr; 34(2):141-144. PubMed ID: 33601876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
    Chang FC; Liu CP; Sun FJ; Lin CC
    J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.
    Akamatsu Y; Morishita S; Chikumi H; Okamoto R; Okada K; Kitaura T; Miyake N; Yamaguchi K; Nakamoto M; Shimohiro H; Takata M; Yamasaki A; Burioka N; Shimizu E
    J Med Invest; 2018; 65(1.2):131-135. PubMed ID: 29593183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
    Olmedo M; Alcalá L; Valerio M; Marín M; Onori R; Reigadas E; Muñoz P; Bouza E
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115050. PubMed ID: 32482380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.